NASDAQ:NXTC - NextCure Stock Price, News, & Analysis

$15.52
+0.40 (+2.65 %)
(As of 06/19/2019 03:36 AM ET)
Today's Range
$15.01
Now: $15.52
$16.20
50-Day Range N/A
52-Week Range
$13.93
Now: $15.52
$22.75
Volume41,058 shs
Average Volume86,002 shs
Market Capitalization$340.43 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for NextCure Inc.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXTC
CUSIPN/A
CIKN/A
Phone240-399-4900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$340.43 million
Next Earnings Date9/9/2019 (Estimated)
OptionableNot Optionable

Receive NXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.

NextCure (NASDAQ:NXTC) Frequently Asked Questions

What is NextCure's stock symbol?

NextCure trades on the NASDAQ under the ticker symbol "NXTC."

When is NextCure's next earnings date?

NextCure is scheduled to release their next quarterly earnings announcement on Monday, September 9th 2019. View Earnings Estimates for NextCure.

What price target have analysts set for NXTC?

2 Wall Street analysts have issued 1 year price targets for NextCure's stock. Their forecasts range from $25.00 to $26.00. On average, they expect NextCure's stock price to reach $25.50 in the next twelve months. This suggests a possible upside of 64.3% from the stock's current price. View Analyst Price Targets for NextCure.

What is the consensus analysts' recommendation for NextCure?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextCure in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NextCure.

Has NextCure been receiving favorable news coverage?

News coverage about NXTC stock has trended very negative on Wednesday, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NextCure earned a media sentiment score of -3.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for NextCure.

Who are some of NextCure's key competitors?

When did NextCure IPO?

(NXTC) raised $75 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofAMerrill Lynch, Pierce and Piper Jaffray served as the underwriters for the IPO.

When did the company's quiet period expire?

NextCure's quiet period expired on Tuesday, June 18th. NextCure had issued 5,000,000 shares in its initial public offering on May 9th. The total size of the offering was $75,000,000 based on an initial share price of $15.00. During the company's quiet period, insiders and underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of NextCure?

Shares of NXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NextCure's stock price today?

One share of NXTC stock can currently be purchased for approximately $15.52.

How big of a company is NextCure?

NextCure has a market capitalization of $340.43 million. View Additional Information About NextCure.

What is NextCure's official website?

The official website for NextCure is http://www.nextcure.com/.

How can I contact NextCure?

NextCure's mailing address is 9000 VIRGINIA MANOR ROAD SUITE 200, BELTSVILLE MD, 20705. The company can be reached via phone at 240-399-4900 or via email at [email protected]


MarketBeat Community Rating for NextCure (NASDAQ NXTC)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  1 (Vote Underperform)
Total Votes:  4
MarketBeat's community ratings are surveys of what our community members think about NextCure and other stocks. Vote "Outperform" if you believe NXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel